SightfileU.S. market data from official filings

CONNECT BIOPHARMA HLDGS LTD (CNTB)

Name: CONNECT BIOPHARMA HLDGS LTD (CNTB) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001835268 · EDGAR filings · Updated 2026-07-01

CONNECT BIOPHARMA HLDGS LTD (CNTB) has reported institutional ownership of 22.6%, with 40 institutional managers holding positions valued at $32.4M per the latest 13F reporting period.

Institutional ownership

22.6%

Institutional managers

Reported 13F value

$32.4M

Latest updates

2026-07-01 — Insider transaction reported (Form 4)
2026-07-01 — Insider transaction reported (Form 4)
2026-06-02 — Insider transaction reported (Form 4)
2026-06-01 — EFFECT filed
2026-05-28 — CORRESP filed
2026-05-22 — UPLOAD filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CONNECT BIOPHARMA HLDGS LTD has 40 institutional holders and institutional ownership of 22.6%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 6 reporting insiders, with a net reported value of $0.

Related companies

TSCAN THERAPEUTICS INC (TCRX) · LIFEVANTAGE CORP (LFVN) · CELLECTIS S A (CLLS) · COYA THERAPEUTICS INC (COYA) · COMPUGEN LTD (CGEN) · AGENUS INC (AGEN)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-01.